Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A18933 | 26861390 | Nutrients | Psoralea corylifolia L. Seed Extract Attenuates Nonalcoholic Fatty Liver Disease in High-Fat Diet-Induced Obese Mice. | 2016 | Details |
| A18936 | 26860405 | J Hepatol | Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis. | 2016 | Details |
| A18940 | 26858440 | Proc Natl Acad Sci U S A | Effective treatment of steatosis and steatohepatitis by fibroblast growth factor 1 in mouse models of nonalcoholic fatty liver disease. | 2016 | Details |
| A18944 | 26856933 | Metabolism | Non-alcoholic fatty liver disease and diabetes. | 2016 | Details |
| A18945 | 26856717 | Dig Dis Sci | Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease. | 2016 | Details |
| A18946 | 26856683 | Clin Obes | Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome. | 2016 | Details |
| A18971 | 26843485 | EMBO J | p38γ and p38δ reprogram liver metabolism by modulating neutrophil infiltration. | 2016 | Details |
| A18977 | 26838182 | Food Funct | Anti-steatotic and anti-inflammatory roles of syringic acid in high-fat diet-induced obese mice. | 2016 | Details |
| A18981 | 26834701 | Front Endocrinol (Lausanne) | Fibroblast Growth Factor Signaling in Metabolic Regulation. | 2016 | Details |
| A18985 | 26831892 | BMC Gastroenterol | A randomised controlled trial of a Mediterranean Dietary Intervention for Adults with Non Alcoholic Fatty Liver Disease (MEDINA): study protocol. | 2016 | Details |
| A18986 | 26831610 | Saudi J Gastroenterol | Effect of telmisartan on histological activity and fibrosis of non-alcoholic steatohepatitis: A 1-year randomized control trial. | 2017 | Details |
| A18987 | 26831557 | J Clin Res Pediatr Endocrinol | Assessment of Cardiovascular Parameters in Obese Children and Adolescents with Non-Alcoholic Fatty Liver Disease. | 2015 | Details |
| A18990 | 26830602 | Rev Paul Pediatr | [Waist circumference as a marker for screening nonalcoholic fatty liver disease in obese adolescents]. | 2015 | Details |
| A18991 | 26829441 | J Clin Endocrinol Metab | Impaired Insulin Suppression of VLDL-Triglyceride Kinetics in Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18998 | 26826574 | Redox Biol | Effects of high fat diets on rodent liver bioenergetics and oxidative imbalance. | 2016 | Details |
| A19001 | 26825546 | Eur J Pharmacol | Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression. | 2016 | Details |
| A19006 | 26823198 | Metabolism | The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). | 2016 | Details |
| A19012 | 26819531 | World J Gastroenterol | Mechanisms of intrahepatic triglyceride accumulation. | 2016 | Details |
| A19013 | 26819197 | Sci Transl Med | The intersection of nonalcoholic fatty liver disease and obesity. | 2016 | Details |
| A19017 | 26817937 | Nutr Metab Cardiovasc Dis | Serum palmitoleate acts as a lipokine in subjects at high cardiometabolic risk. | 2015 | Details |
| A19019 | 26817127 | Eksp Klin Gastroenterol | [NONALCOHOLIC FATTY LIVER DISEASE: DIAGNOSTIC, SYMPTOMS, TREATMENT. GUIDELINES WERE APPROVED BY THE XV GASTROENTEROLOGICAL SCIENTIFIC SOCIETY OF RUSSIA IN 2015]. | 2015 | Details |
| A19024 | 26814015 | Am J Physiol Endocrinol Metab | Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity. | 2016 | Details |
| A19025 | 26813367 | Zhonghua Yi Xue Za Zhi | [Clinical features of non-alcoholic fatty liver disease and its relationship with serum C-peptide levels in patients with latent autoimmune diabetes in adults]. | 2015 | Details |
| A19028 | 26812459 | J Adolesc Young Adult Oncol | Metabolic Health in Childhood Cancer Survivors: A Longitudinal Study in a Long-Term Follow-Up Clinic. | 2015 | Details |
| A19032 | 26811103 | Exp Biol Med (Maywood) | Women may respond different from men to vitamin D supplementation regarding cardiometabolic biomarkers. | 2016 | Details |
| A19044 | 26806650 | Hepatology | Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice. | 2016 | Details |
| A19047 | 26805014 | Metabolism | Exercise and diet in the management of nonalcoholic fatty liver disease. | 2015 | Details |
| A19048 | 26803754 | Obes Surg | The Correlation Between Obesity-Related Diseases and Non-alcoholic Fatty Liver Disease in Women in the Pre-operative Evaluation for Bariatric Surgery Assessed by Transient Hepatic Elastography. | 2016 | Details |
| A19050 | 26803355 | Diabetes Res Clin Pract | Circulating adiponectin levels in type 2 diabetes mellitus patients with or without non-alcoholic fatty liver disease: Results of a small, open-label, randomized controlled intervention trial in a subgroup receiving short-term exenatide. | 2016 | Details |
| A19051 | 26800495 | J Diabetes | Age at menarche is associated with the prevalence of non-alcoholic fatty liver disease later in life. | 2016 | Details |
| A19055 | 26797396 | Am J Physiol Gastrointest Liver Physiol | Pioglitazone attenuates hepatic inflammation and fibrosis in phosphatidylethanolamine N-methyltransferase-deficient mice. | 2016 | Details |
| A19058 | 26794005 | J Gastroenterol | Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice. | 2016 | Details |
| A19061 | 26791191 | Am J Clin Nutr | Serum aminotransferases in nonalcoholic fatty liver disease are a signature of liver metabolic perturbations at the amino acid and Krebs cycle level. | 2016 | Details |
| A19063 | 26788524 | J Diabetes Res | A Novel Wistar Rat Model of Obesity-Related Nonalcoholic Fatty Liver Disease Induced by Sucrose-Rich Diet. | 2015 | Details |
| A19066 | 26786607 | Sao Paulo Med J | Influence of type 2 diabetes mellitus on liver histology among morbidly obese individuals. A cross-sectional study. | 2016 | Details |
| A19067 | 26786351 | Int J Obes (Lond) | Strong and persistent effect on liver fat with a Paleolithic diet during a two-year intervention. | 2016 | Details |
| A19068 | 26785389 | Hepatol Res | The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment. | 2016 | Details |
| A19069 | 26784973 | Scand J Gastroenterol | Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease. | 2016 | Details |
| A19074 | 26783443 | Clin Case Rep | Insulin detemir may be less efficacious in patients with nonalcoholic fatty liver disease and hypertriglyceridemia. | 2015 | Details |
| A19075 | 26780287 | J Hepatol | Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A19082 | 26775559 | Metabolism | Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2015 | Details |
| A19083 | 26775542 | Biosci Biotechnol Biochem | Long-term fatty liver-induced insulin resistance in orotic acid-induced nonalcoholic fatty liver rats. | 2016 | Details |
| A19084 | 26774456 | Biochem Pharmacol | Coral calcium hydride prevents hepatic steatosis in high fat diet-induced obese rats: A potent mitochondrial nutrient and phase II enzyme inducer. | 2016 | Details |
| A19091 | 26770987 | J Diabetes Res | Nutrition and Physical Activity in Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19095 | 26770473 | Int J Clin Exp Med | Absence of non-alcoholic fatty liver disease in the presence of insulin resistance is a strong predictor for colorectal carcinoma. | 2015 | Details |
| A19102 | 26765961 | Aliment Pharmacol Ther | I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders. | 2016 | Details |
| A19107 | 26761949 | J Clin Res Pediatr Endocrinol | Sex Hormone-Binding Globulin in Children and Adolescents. | 2015 | Details |
| A19109 | 26758497 | J Clin Res Pediatr Endocrinol | Relationship between Neck Circumference and Non-Alcoholic Fatty Liver Disease in Childhood Obesity. | 2015 | Details |
| A19112 | 26756202 | Diabet Med | Familial partial lipodystrophy linked to a novel peroxisome proliferator activator receptor -γ (PPARG) mutation, H449L: a comparison of people with this mutation and those with classic codon 482 Lamin A/C (LMNA) mutations. | 2016 | Details |
| A19113 | 26755885 | World J Gastroenterol | Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents. | 2016 | Details |
| A19114 | 26755867 | World J Gastroenterol | Association between hepatitis B and metabolic syndrome: Current state of the art. | 2016 | Details |
| A19115 | 26755815 | J Investig Med | Plasma thyroid hormone concentration is associated with hepatic triglyceride content in patients with type 2 diabetes. | 2015 | Details |
| A19117 | 26753695 | Naunyn Schmiedebergs Arch Pharmacol | Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis. | 2016 | Details |
| A19126 | 26743335 | Nat Commun | mTORC1-independent Raptor prevents hepatic steatosis by stabilizing PHLPP2. | 2016 | Details |
| A19132 | 26739624 | Toxicol Appl Pharmacol | A cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: Application to acetaminophen. | 2015 | Details |
| A19136 | 26733747 | Clujul Med | Non-alcoholic fatty liver disease severity, central fat mass and adinopectin: a close relationship. | 2015 | Details |
| A19137 | 26733244 | Physiol Rep | Novel hepatic microRNAs upregulated in human nonalcoholic fatty liver disease. | 2016 | Details |
| A19139 | 26732252 | Sci Rep | Aliskiren Reduces Hepatic steatosis and Epididymal Fat Mass and Increases Skeletal Muscle Insulin Sensitivity in High-Fat Diet-Fed Mice. | 2016 | Details |
| A19142 | 26731267 | PLoS One | The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice. | 2016 | Details |
| A19144 | 26728862 | Turk J Gastroenterol | Ovaries are more vulnerable than hepatocytes for insulin resistance and hyperinsulinemia. | 2016 | Details |
| A19145 | 26728692 | J Intern Med | Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia. | 2016 | Details |
| A19146 | 26728273 | BMB Rep | The role of lipids in the pathogenesis and treatment of type 2 diabetes and associated co-morbidities. | 2016 | Details |
| A19155 | 26725058 | Dig Dis Sci | Function of Autophagy in Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A19157 | 26724391 | Eur J Pharmacol | Lipid-lowering agents inhibit hepatic steatosis in a non-alcoholic steatohepatitis-derived hepatocellular carcinoma mouse model. | 2015 | Details |
| A19160 | 26720346 | Cell Death Dis | Obesity and cancer, a case for insulin signaling. | 2015 | Details |
| A19161 | 26719755 | Nutr Metab (Lond) | Neck circumference as an independent indicator to non-alcoholic fatty liver disease in non-obese men. | 2015 | Details |
| A19162 | 26718936 | J Diabetes Complications | Optimal cutoff points for HOMA-IR and QUICKI in the diagnosis of metabolic syndrome and non-alcoholic fatty liver disease: A population based study. | 2015 | Details |
| A19178 | 29889391 | Eksp Klin Gastroenterol | NON-ALCOHOLIC FATTY LIVER DISEASE IN ELDERLY. | 2018 | Details |
| A19182 | 29201718 | Euroasian J Hepatogastroenterol | Reduced Glutathione suppresses Oxidative Stress in Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A19186 | 28670148 | Clin Med Insights Ther | Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options. | 2016 | Details |
| A19188 | 28614648 | Eksp Klin Gastroenterol | [[The Modern View on Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease].] | 2016 | Details |
| A19190 | 28332698 | Mol Med | Induction of steatohepatitis (NASH) with insulin resistance in wildtype B6 mice by a western-type diet containing soybean oil and cholesterol. | 2017 | Details |
| A19196 | 26713058 | J Korean Med Sci | Vitamin D Status and Bone Mineral Density in Obese Children with Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19211 | 26699443 | J Gastroenterol Hepatol | Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice. | 2016 | Details |
| A19213 | 26698881 | J Biol Chem | The Hepatitis C Virus-induced NLRP3 Inflammasome Activates the Sterol Regulatory Element-binding Protein (SREBP) and Regulates Lipid Metabolism. | 2015 | Details |
| A19220 | 26697286 | Springerplus | Global publication trends and research hotspots of nonalcoholic fatty liver disease: a bibliometric analysis and systematic review. | 2015 | Details |
| A19222 | 26695389 | Can J Physiol Pharmacol | Irisin levels in relation to metabolic and liver functions in Egyptian patients with metabolic syndrome. | 2015 | Details |
| A19226 | 26690419 | Int J Mol Sci | Overnutrition Determines LPS Regulation of Mycotoxin Induced Neurotoxicity in Neurodegenerative Diseases. | 2015 | Details |
| A19227 | 26690233 | J Clin Med | MicroRNAs in Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19232 | 26683215 | Endocr Dev | Docosahexaenoic Acid and Its Role in G-Protein-Coupled Receptor 120 Activation in Children Affected by Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19239 | 26678309 | BMC Gastroenterol | Deficiency of eNOS exacerbates early-stage NAFLD pathogenesis by changing the fat distribution. | 2015 | Details |
| A19240 | 26678239 | J Gastroenterol Hepatol | Follicle-stimulating hormone is associated with non-alcoholic fatty liver disease in Chinese women over 55 years old. | 2016 | Details |
| A19242 | 26676813 | Semin Liver Dis | Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19244 | 26675585 | BBA Clin | Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients. | 2014 | Details |
| A19249 | 26674248 | BBA Clin | Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy. | 2015 | Details |
| A19253 | 26672634 | J Clin Endocrinol Metab | Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD. | 2015 | Details |
| A19256 | 26670487 | Am J Physiol Endocrinol Metab | Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD. | 2015 | Details |
| A19259 | 26668692 | World J Hepatol | Bile acid receptors and nonalcoholic fatty liver disease. | 2015 | Details |
| A19268 | 26666594 | Intern Med | The Symptoms of Gastroesophageal Reflux Disease Correlate with High Body Mass Index, the Aspartate Aminotransferase/Alanine Aminotransferase Ratio and Insulin Resistance in Japanese Patients with Non-alcoholic Fatty Liver Disease. | 2015 | Details |
| A19272 | 26663034 | Acta Physiol (Oxf) | Gastric bypass surgery is protective from high-fat diet-induced non-alcoholic fatty liver disease and hepatic endoplasmic reticulum stress. | 2015 | Details |
| A19277 | 26660688 | Obes Surg | Combined Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Sleeve Gastrectomy or Gastric Bypass?-a Controlled Matched Pair Study of 34 Patients. | 2016 | Details |
| A19287 | 26650570 | Endocrinology | Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice. | 2015 | Details |
| A19289 | 26648069 | Curr Drug Targets | Biology, Epidemiology, Clinical Aspects of Hepatocellular Carcinoma and the Role of Sorafenib. | 2016 | Details |
| A19290 | 26646939 | Sci Data | Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes. | 2015 | Details |
| A19292 | 26645107 | J Cell Mol Med | Role of stem cells during diabetic liver injury. | 2015 | Details |
| A19295 | 26642701 | Clin Lab | Therapeutic Effect of Metformin on Chemerin in Non-Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD). | 2015 | Details |
| A19296 | 26641143 | Expert Rev Gastroenterol Hepatol | The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development--a potential therapeutic target? | 2015 | Details |
| A19299 | 26639394 | J Hepatol | Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. | 2015 | Details |
| A19304 | 26638128 | Hepatology | Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011). | 2016 | Details |
| A19306 | 26636520 | Eur Rev Med Pharmacol Sci | Is it possible a new definition of metabolic syndrome in childhood? | 2015 | Details |